Загрузка...
Raloxifene and anti-estrogenic Gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem like cells
Studies suggest that estrogen plays a contributing role in colorectal cancer (CRC). This project examined the preventive effects of raloxifene, a selective estrogen receptor modulator (SERM), and gonadorelin, an anti-estrogenic drug, in female Apc(Min/+) mouse intestinal tumorigenesis. Six-week-old...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3951612/ https://ncbi.nlm.nih.gov/pubmed/24431404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-13-0345 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|